Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia

समान संसाधन

• The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents
  द्वारा: STRAY-PEDERSEN, A, और अन्य
  प्रकाशित: (2004)
• Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
  द्वारा: Hoffman, Thijs W., और अन्य
  प्रकाशित: (2020)
• Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine
  द्वारा: Rose, Markus A., और अन्य
  प्रकाशित: (2005)
• Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae
  द्वारा: Turner, Allison E.B., और अन्य
  प्रकाशित: (2017)
• Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
  द्वारा: Shiramoto, Masanari, और अन्य
  प्रकाशित: (2015)